Attenuation of renal ischemia-reperfusion injury in rats by allopurinol and prostaglandin E1. 1998

P C Gupta, and M Matsushita, and K Oda, and N Nishikimi, and T Sakurai, and Y Nimura
First Department of Surgery, Nagoya University School of Medicine, Japan.

50 Sprague-Dawley rats were used to study the effect of allopurinol and prostaglandin E1 (PGE1) on renal ischemia-reperfusion injury. They underwent left renal ischemia for 1 h and reperfusion. A right nephrectomy was performed, and 5 groups were made. Group AP received allopurinol 50 mg/kg and PGE1 20 micrograms/kg; group A, allopurinol; group P, PGE1; group C, control, and group S, sham group. Five animals from each group were used to study renal functions and 5 for renal histology. The serum creatinine values were lower in the treatment groups compared to the controls on days 1-3 and 7 (p < 0.05). The blood urea nitrogen values showed a similar trend. Maximum histological damage was seen in group C, followed by groups A, P and AP, in this order. We conclude that allopurinol and PGE1 attenuate renal ischemia-reperfusion injury in rats.

UI MeSH Term Description Entries
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D001806 Blood Urea Nitrogen The urea concentration of the blood stated in terms of nitrogen content. Serum (plasma) urea nitrogen is approximately 12% higher than blood urea nitrogen concentration because of the greater protein content of red blood cells. Increases in blood or serum urea nitrogen are referred to as azotemia and may have prerenal, renal, or postrenal causes. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984) BUN,Nitrogen, Blood Urea,Urea Nitrogen, Blood
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D000493 Allopurinol A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms. Allohexal,Allohexan,Alloprin,Allopurin,Allorin,Allpargin,Allural,Apulonga,Apurin,Atisuril,Bleminol,Caplenal,Capurate,Cellidrin,Embarin,Foligan,Hamarin,Jenapurinol,Lopurin,Lysuron,Milurit,Milurite,Novopurol,Pan Quimica,Progout,Pureduct,Purinol,Remid,Rimapurinol,Roucol,Suspendol,Tipuric,Uribenz,Uridocid,Uripurinol,Urosin,Urtias,Xanthomax,Xanturic,Zygout,Zyloprim,Zyloric
D000527 Alprostadil A potent vasodilator agent that increases peripheral blood flow. PGE1,Prostaglandin E1,Caverject,Edex,Lipo-PGE1,Minprog,Muse,PGE1alpha,Prostaglandin E1alpha,Prostavasin,Prostin VR,Prostine VR,Sugiran,Vasaprostan,Viridal,Lipo PGE1
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries

Related Publications

P C Gupta, and M Matsushita, and K Oda, and N Nishikimi, and T Sakurai, and Y Nimura
June 1995, Journal of the American College of Surgeons,
P C Gupta, and M Matsushita, and K Oda, and N Nishikimi, and T Sakurai, and Y Nimura
September 2016, Toxicology and industrial health,
P C Gupta, and M Matsushita, and K Oda, and N Nishikimi, and T Sakurai, and Y Nimura
January 2007, Nephron. Physiology,
P C Gupta, and M Matsushita, and K Oda, and N Nishikimi, and T Sakurai, and Y Nimura
January 2015, Transplantation proceedings,
P C Gupta, and M Matsushita, and K Oda, and N Nishikimi, and T Sakurai, and Y Nimura
May 1994, Pancreas,
P C Gupta, and M Matsushita, and K Oda, and N Nishikimi, and T Sakurai, and Y Nimura
June 2002, Surgery,
P C Gupta, and M Matsushita, and K Oda, and N Nishikimi, and T Sakurai, and Y Nimura
February 1995, Zhonghua nei ke za zhi,
P C Gupta, and M Matsushita, and K Oda, and N Nishikimi, and T Sakurai, and Y Nimura
August 2000, Shock (Augusta, Ga.),
P C Gupta, and M Matsushita, and K Oda, and N Nishikimi, and T Sakurai, and Y Nimura
January 1998, Circulation,
P C Gupta, and M Matsushita, and K Oda, and N Nishikimi, and T Sakurai, and Y Nimura
July 2000, Critical care medicine,
Copied contents to your clipboard!